Recruiting
Phase 1
Phase 2

NG101 AAV Gene Therapy in Subjects With Wet Age-Related Macular Degeneration

Sponsor:

Neuracle Genetics, Inc

Code:

NCT05984927

Conditions

Age-Related Macular Degeneration

Eligibility Criteria

Sex: All

Age: 50 - 70+

Healthy Volunteers: Not accepted

Interventions

NG101 AAV gene therapy

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information